Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    CD24 Antibody (SN3), DyLight 350, Novus Biologicals™
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Mouse Monoclonal Antibody
Supplier: Novus Biologicals NB10064861UV
Description
CD24 Monoclonal specifically detects CD24 in Human samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Frozen.Specifications
| CD24 | |
| Monoclonal | |
| DyLight 350 | |
| 50mM Sodium Borate with 0.05% Sodium Azide | |
| CD24 | |
| Glycoproteins purified from human NALM-1 cell line | |
| 0.1 mL | |
| B Cell Development and Differentiation Markers, Cancer, Neuronal Cell Markers, Neuronal Stem Cell Markers, Stem Cell Markers | |
| 100133941 | |
| Human | |
| Purified | 
| Flow Cytometry, Immunohistochemistry, Immunohistochemistry (Frozen) | |
| SN3 | |
| Flow Cytometry, Immunohistochemistry, Immunohistochemistry-Frozen | |
| CD 24, CD24 antigen, CD24 antigen (small cell lung carcinoma cluster 4 antigen), CD24 molecule, CD24Asignal transducer CD24, FLJ22950, FLJ43543, MGC75043, Small cell lung carcinoma cluster 4 antigen | |
| Mouse | |
| Protein G purified | |
| RUO | |
| Primary | |
| Recognizes the human CD24 cell surface antigen, a heavily glycosylated molecule of 35-45kD. CD24 is expressed by granulocytes and B lymphocytes, and by some activated T cells and T cell malignancies. | |
| Store at 4C in the dark. | |
| IgG1 | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            Spot an opportunity for improvement?Share a Content Correction